Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.

"Conflicts of interest Andreas Zuckermann has received research funding and is a member of an advisory board for Sanofi-Genzyme. Uwe Schulz has received speaker's honoraria from Sanofi-Genzyme. Andres Beiras-Fernandez has received research funding from Sanofi-Genzyme, Fresenius Biotech, Novartis, Pfizer and Astellas Pharma and is/was a member of advisory boards for Sanofi-Genzyme, Astellas Pharma, Fresenius Biotech, Novartis, Merck, and Abbott. Laurence Kopp-Fernandes has received honoraria from an advisor contract with Sanofi-Aventis. The other authors have no conflicts of interest to declare."

"Funding The authors received travel funding from Sanofi to attend a meeting at which the data for inclusion in the paper were discussed and presentations made by the authors."